Open access
Jul 2026
Abbapolin inhibitors of the PLK1 PBD as Prostate Cancer Therapeutics, in vivo activity and synergy with androgen therapy
George Merhej, Gurusankar Ramamoorthy, Danda Chapagai et al.
· bioRxiv · 0 citations